A process comprising codon optimization for the production of recombinant activated human protein C for the treatment of sepsis

Details for Australian Patent Application No. 2006250889 (hide)

Owner Avestha Gengraine Technologies Pvt Ltd

Inventors Patell, Villoo Morawala

Agent Spruson & Ferguson

Pub. Number AU-A-2006250889

PCT Pub. Number WO2006/126070

Priority 626/CHE/2005 24.05.05 IN

Filing date 24 May 2006

Wipo publication date 30 November 2006

International Classifications

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2006/126070 Priority application(s): WO2006/126070

24 April 2008 Alteration of Name

  The name of the applicant has been altered to Avesthagen Limited

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006250905-Angiotensin I - converting enzyme (ACE) inhibitors

2006250888-A method for the production of a monoclonal antibody to CD20 for the treatment of B-cell lymphoma